{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:28:29Z","timestamp":1792553309115,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060745"],"award-info":[{"award-number":["82060745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.taap.2023.116438","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T09:21:07Z","timestamp":1677230467000},"page":"116438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines"],"prefix":"10.1016","volume":"464","author":[{"given":"Hancheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengke","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2023.116438_bb0005","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/nar\/gkz120","article-title":"Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins","volume":"47","author":"Alemasova","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2023.116438_bb0010","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/gutjnl-2016-313314","article-title":"BMP-9 interferes with liver regeneration and promotes liver fibrosis","volume":"66","author":"Breitkopf-Heinlein","year":"2017","journal-title":"Gut."},{"key":"10.1016\/j.taap.2023.116438_bb0015","article-title":"5-O-Demethylnobiletin alleviates CCl(4)-induced acute liver injury by equilibrating ROS-mediated apoptosis and autophagy induction","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116438_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2019.152338","article-title":"Kaempferol alleviates acute alcoholic liver injury in mice by regulating intestinal tight junction proteins and butyrate receptors and transporters","volume":"429","author":"Chen","year":"2020","journal-title":"Toxicology."},{"key":"10.1016\/j.taap.2023.116438_bb0025","first-page":"U313","article-title":"Use of PYMOL as a communications tool for molecular science","volume":"228","author":"DeLano","year":"2004","journal-title":"Abstr. Pap. Am. Chem. Soc."},{"key":"10.1016\/j.taap.2023.116438_bb0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0168-8278(03)00005-9","article-title":"Knodell RG, Ishak KG, black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [hepatology 1981;1:431-435]","volume":"38","author":"Desmet","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2023.116438_bb0035","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver Fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.taap.2023.116438_bb0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/lt.25434","article-title":"Current knowledge, barriers to implementation, and future directions in palliative Care for end-Stage Liver Disease","volume":"25","author":"Fricker","year":"2019","journal-title":"Liver Transpl."},{"key":"10.1016\/j.taap.2023.116438_bb0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology."},{"key":"10.1016\/j.taap.2023.116438_bb0050","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/ijms21082767","article-title":"Mitochondrial protection by PARP inhibition","volume":"21","author":"Gallyas","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2023.116438_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201600392","article-title":"The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice","volume":"61","author":"Geng","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.taap.2023.116438_bb0060","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cbi.2018.07.008","article-title":"New insights into TGF-\u03b2\/Smad signaling in tissue fibrosis","volume":"292","author":"Hu","year":"2018","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2023.116438_bb0065","first-page":"188","article-title":"Ethanol extract of Euonymus alatus preventing liver fibrosis in mice and its preliminary mechanism","volume":"42","author":"Huang","year":"2022","journal-title":"Chin. J. Dig."},{"key":"10.1016\/j.taap.2023.116438_bb0070","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2023.116438_bb0075","doi-asserted-by":"crossref","first-page":"13692","DOI":"10.1038\/s41598-021-92846-0","article-title":"Visualization and modeling of inhibition of IL-1\u03b2 and TNF-\u03b1 mRNA transcription at the single-cell level","volume":"11","author":"Kalb","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2023.116438_bb0080","article-title":"Curcumin blunts epithelial-mesenchymal transition of hepatocytes to alleviate hepatic fibrosis through regulating oxidative stress and autophagy","volume":"36","author":"Kong","year":"2020","journal-title":"Redox Miol."},{"key":"10.1016\/j.taap.2023.116438_bb0085","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.sbi.2013.01.003","article-title":"PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis","volume":"23","author":"Langelier","year":"2013","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.taap.2023.116438_bb0090","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jcmm.12967","article-title":"HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-\u03b2\/SMAD signalling pathway","volume":"21","author":"Lucarini","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.taap.2023.116438_bb0095","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.taap.2023.116438_bb0100","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.26763","article-title":"Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis","volume":"59","author":"Mukhopadhyay","year":"2014","journal-title":"Hepatology."},{"key":"10.1016\/j.taap.2023.116438_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.10.023","article-title":"PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis","volume":"66","author":"Mukhopadhyay","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2023.116438_bb0110","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.2147\/IJN.S145951","article-title":"Nanoparticles for the treatment of liver fibrosis","volume":"12","author":"Poilil Surendran","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.taap.2023.116438_bb0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.drudis.2020.04.019","article-title":"\u2018PARP\u2019ing fibrosis: repurposing poly (ADP ribose) polymerase (PARP) inhibitors","volume":"25","author":"Rao","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2023.116438_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105765","article-title":"Research progress on the anti-hepatic fibrosis action and mechanism of natural products","volume":"75","author":"Shan","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2023.116438_bb0125","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.taap.2023.116438_bb0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1152\/physrev.00036.2017","article-title":"Sources of vascular nitric oxide and reactive oxygen species and their regulation","volume":"99","author":"Tejero","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.taap.2023.116438_bb0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.taap.2023.116438_bb0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2023.116438_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030278","article-title":"Design of a Gene Panel to expose the versatile role of hepatic stellate cells in human liver fibrosis","volume":"12","author":"van Dijk","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.taap.2023.116438_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2019.102651","article-title":"PARP-1 and its associated nucleases in DNA damage response","volume":"81","author":"Wang","year":"2019","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.taap.2023.116438_bb0155","doi-asserted-by":"crossref","first-page":"9289","DOI":"10.1038\/s41598-017-09673-5","article-title":"Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-\u03b21\/Smads and PI3K\/Akt pathways","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2023.116438_bb0160","first-page":"103","article-title":"Margatoxin mitigates CCl4-induced hepatic fibrosis in mice via macrophage polarization, cytokine secretion and STAT signaling","volume":"45","author":"Wu","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.taap.2023.116438_bb0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/hep.31801","article-title":"TNF-\u03b1-induce protein 8-like 1 inhibits hepatic steatosis, inflammation, and fibrosis by suppressing Polyubiquitination of apoptosis signal-regulating kinase 1","volume":"74","author":"Wu","year":"2021","journal-title":"Hepatology."},{"key":"10.1016\/j.taap.2023.116438_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fmed.2020.00071","article-title":"Myricetin modulates macrophage polarization and mitigates liver inflammation and fibrosis in a murine model of nonalcoholic steatohepatitis","volume":"7","author":"Yao","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.taap.2023.116438_bb0175","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1182\/blood-2013-05-503250","article-title":"PARP-1 regulates expression of TGF-\u03b2 receptors in T cells","volume":"122","author":"Zhang","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.taap.2023.116438_bb0180","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41419-020-2429-9","article-title":"Imbalance in mitochondrial dynamics induced by low PGC-1\u03b1 expression contributes to hepatocyte EMT and liver fibrosis","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.taap.2023.116438_bb0185","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1002\/ptr.7104","article-title":"Quercetin as a protective agent for liver diseases: a comprehensive descriptive review of the molecular mechanism","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother. Res."},{"key":"10.1016\/j.taap.2023.116438_bb0190","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.tim.2021.01.002","article-title":"When PARPs meet antiviral innate immunity","volume":"29","author":"Zhu","year":"2021","journal-title":"Trends Microbiol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X23000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:01:17Z","timestamp":1758574877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X23000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":38,"alternative-id":["S0041008X23000765"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2023.116438","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydrokaempferol attenuates CCl4-induced hepatic fibrosis by inhibiting PARP-1 to affect multiple downstream pathways and cytokines","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2023.116438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116438"}}